Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
Wen-Fan Shen,Jedhan Ucat Galula,Jyung-Hurng Liu,Mei-Ying Liao,Cheng-Hao Huang,Yu-Chun Wang,Han-Chung Wu,Jian-Jong Liang,Yi-Ling Lin,Matthew T Whitney,Gwong-Jen J Chang,Sheng-Ren Chen,Shang-Rung Wu,Day-Yu Chao,Yi-ling Lin,Gwong-jen J Chang,Jian-jong Liang,Chang-hao Huang,Mei-ying Liao,Wen-fan Shen,Day-yu Chao,Sheng-ren Chen,Yu-chun Wang,Shang-rung Wu,Han-chung Wu,Jyung-hurng Liu
DOI: https://doi.org/10.7554/eLife.38970
IF: 7.7
2019-10-04
eLife
Abstract:Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein VLP derived from DENV serotype-2 were engineered becoming highly matured (mD2VLP) and showed variable size distribution with diameter of ~31nm forming the major population under cryo-electron microscopy examination. Furthermore, mD2VLP particles of 31nm diameter possess a T=1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes. Mice vaccinated with mD2VLP generated higher cross-reactive (CR) neutralization antibodies (NtAbs) and were fully protected against all 4 serotypes of DENV. Our results highlight the potential of 'epitope-resurfaced' mature-form D2VLPs in inducing quaternary structure-recognizing broad CR NtAbs to guide future dengue vaccine design.
biology